Abstract
Human immunodeficiency virus (HIV) infection is a growing concern for health workers. The two major components of dyslipidemia in HIV infected patients are hypertriglyceridemia and decreased levels of high density lipoprotein (HDL) which contribute to increased atherosclerotic risk. The study included 150 newly diagnosed HIV patients and 150 healthy controls. In all these cases Lecithin cholesterol acyl transferase (LCAT) activity was assessed by measuring the difference between esterified and free cholesterol by digitonin precipitation method and levels of Apolipoprotein A-I (apo A-I) were measured by immunoturbidimetric method. There was a significantly decreased LCAT activity (p < 0.05) as well as reduced levels of apo A-I (p < 0.05) in newly diagnosed HIV patients (54.98 ± 3.44 IU/L and 131.85 ± 8.49 mg/dl) when compared with healthy controls (88.17 ± 14.36 IU/L and 187.05 ± 35.25 mg/dL). A significant positive correlation (r = 0.7406) was found between LCAT activity and apo A-I levels. In conclusion decreased LCAT activity and decreased levels of apo A-I reduce the reverse cholesterol transport in newly diagnosed HIV patients which may lead to atherosclerosis in the future.
Similar content being viewed by others
References
UNAIDS. Report on the global AIDS epidemic 2014. Available at http://www.unaids.org/en/resources/campaigns/World-AIDS-Day-Report-2014/factsheet.
Garg S, Singh R. Getting to zero: possibility or propaganda? Indian J Sex Transm Dis. 2013;34:1–4.
Fauci AS. The AIDS epidemic-considerations for the 21st century. N Engl J Med. 1999;341:1046–50.
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–60.
Sprinz E, Lazzaretti RK, Kuhmmer R, Ribeiro JP. Dyslipidemia in HIV infected individuals. Braz J Infect Dis. 2010;14(6):575–88.
Francesehini G, Maderna P, Sirtori CR. Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis. 1991;88:99–107.
Krimbou L, Marcil M, Davignon J, Genest J. Interaction of LCAT alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein. Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance. J Biol Chem. 2001;276(35):33241–8.
Kwiterovich PO. The anti atherogenic role of high-density lipoprotein cholesterol. Am J Cardiol. 1998;82:13–21.
Gowland E. Lipids and lipoproteins. In: Varley’s practical clinical biochemistry. 4th edn. New Dehli. CBS; 2005;311–13.
Nader Rifai, Russell Warnick G. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors In: Teitz textbook of clinical and molecular diagnostics. 4th edn. Philadelpia; W.B.Saunders. 2006; 955–60.
Barbaro G. Cardiovascular manifestations of HIV infection. Circulation. 2002;106:1420–5.
El-Sadr WM, Mullin CM, Carr A, Gibert C, Rappoport C, Visnegarwala F, et al. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med. 2005;6:114–21.
Escaut L, Monsuez JJ, Chironi G, Merad M, Teicher E, Smadja D, et al. Coronary artery disease in HIV infected patients. Intensive Care Med. 2003;29:969–73.
Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109:1603–8.
Blum A, Hadas V, Burke M, Yust I, Kessler A. Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol. 2005;28:149–53.
Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN. Hypertriglyceridemia in acquired immunodeficiency syndrome. Am J Med. 1989;86(1):27–31.
Penzak SR, Chuck SK. Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. Scand J Infect Dis. 2000;32(2):111–23.
Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, et al. HIV infection and high density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism. 2006;55(1):90–5.
Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett PH. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and non diabetics. Arteriosclerosis. 1984;4(5):462–71.
Crook MA, Mir N. Abnormal lipids and the acquired immune deficient syndrome is there a problem and what should we do about it. Intl J STD AIDS. 1999;10(6):353–6.
Greene DJ, Skeggs JW, Morton RE. Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI). J Biol Chem. 2001;276:4804–11.
Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler Thromb Vasc Biol. 2003;23:1914–20.
Stein TP, Nutinsky C, Conduluci D, Schulter MD, Leskiw MJ. Protein and substrate metabolism in AIDS patients. Metabolism. 1990;39(8):876–81.
Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, et al. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS. 2011;25(17):2133–42.
Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992;74:1045–52.
Acknowledgements
The authors would like to express their sincere thanks and gratitude to all the participants involved in the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mirajkar, A., Nikam, S., Nikam, P. et al. Role of LCAT and Apo A-I in Newly Diagnosed HIV Patients. Ind J Clin Biochem 32, 459–463 (2017). https://doi.org/10.1007/s12291-016-0631-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-016-0631-4